Drug lookup
Drug reference

adrenaline

Vasoconstrictor (implied by use with local anesthetics. Removing.)

Vasoconstrictor (implied by use with local anesthetics. Removing.)
CDSCO approved
EXCRETION
not curated
INTERACTIONS
12 major
incl. contraindicated
PREGNANCY
not curated
Top interactionssee all 12
  • HalothaneContraindicatedTextbookKDT 7e · p133
  • AcebutololSevereTextbookKDT 7e · p133
  • AmitriptylineSevereTextbookKDT 7e · p365
  • AmoxapineSevereTextbookKDT 7e · p365

Mechanism

Not yet extracted

Indications

anaphylactic shockangioedema of larynxbronchospasm attending drug hypersensitivityLocal vasoconstrictor (with lidocaine)Cardiac arrest (to stimulate heart, with external cardiac massage)UrticariaAngioedemaLaryngeal edemaControl of local bleeding (from skin, mucous membranes)Insulin hypoglycaemiaOvercoming partial heart blockMaintaining a sufficient idioventricular rate in complete (3rd degree) heart block (until external pacemaker can be implanted)

Dosing

Adult
0.5 mg (0.5 ml of 1 in 1000 solution) i.m.; repeat every 5–10 min in case patient does not improve or improvement is transient. If i.v., it should be diluted to 1:10,000 or 1:100,000 and infused slowly with constant monitoring.
Pediatric
0.3 ml for child 6-12 years and 0.15 ml for child upto 6 years (i.m.)
Max dose
1 mg/ml inj; 4 mg (of Adr. bitartrate=2mg Adr. base)/2 ml inj

Pharmacokinetics

Duration
0.5–2 hrs
Metabolism
Adrenaline is oxidized by monoamine oxidase and methylated by methyl transferases.

Contraindications

  • Hypertensive patients
  • Hyperthyroid patients
  • Angina patients
  • During anaesthesia with halothane
  • Patients receiving β blockers

Side effects

Common
Transient restlessnessHeadachePalpitationAnxietyTremorPallor
Serious
  • fatal if injected i.v. inappropriately
  • Marked rise in BP leading to cerebral haemorrhage
  • Ventricular tachycardia/fibrillation
  • Angina
  • Myocardial infarction
  • Pulmonary edema (toxic doses)

Drug interactions

Halothane
Contraindicated
Textbook

Ventricular arrhythmias.

Adrenaline should not be given during anaesthesia with halothane.

Source: KDT 7e · p133

Acebutolol
Severe
Textbook

Marked rise in BP.

Adrenaline should not be given to patients receiving β blockers.

Source: KDT 7e · p133

Amitriptyline
Severe
Textbook

Potentiation of adrenaline's effects.

Vasoconstrictor (adrenaline) containing LA should be avoided in patients receiving tricyclic antidepressants.

Source: KDT 7e · p365

Amoxapine
Severe
Textbook

Potentiation of adrenaline's effects.

Vasoconstrictor (adrenaline) containing LA should be avoided in patients receiving tricyclic antidepressants.

Source: KDT 7e · p365

Atenolol
Severe
Textbook

Marked rise in BP.

Adrenaline should not be given to patients receiving β blockers.

Source: KDT 7e · p133

Betaxolol
Severe
Textbook

Marked rise in BP.

Adrenaline should not be given to patients receiving β blockers.

Source: KDT 7e · p133

Bisoprolol
Severe
Textbook

Marked rise in BP.

Adrenaline should not be given to patients receiving β blockers.

Source: KDT 7e · p133

Bucindolol
Severe
Textbook

Marked rise in BP.

Adrenaline should not be given to patients receiving β blockers.

Source: KDT 7e · p133

Carteolol
Severe
Textbook

Marked rise in BP.

Adrenaline should not be given to patients receiving β blockers.

Source: KDT 7e · p133

Carvedilol
Severe
Textbook

Marked rise in BP.

Adrenaline should not be given to patients receiving β blockers.

Source: KDT 7e · p133

Celiprolol
Severe
Textbook

Marked rise in BP.

Adrenaline should not be given to patients receiving β blockers.

Source: KDT 7e · p133

Clomipramine
Severe
Textbook

Potentiation of adrenaline's effects.

Vasoconstrictor (adrenaline) containing LA should be avoided in patients receiving tricyclic antidepressants.

Source: KDT 7e · p365

Related guidelines

Other Unclassified drugs

Ask House about adrenaline

Continue into a citation-backed clinical answer with the drug context already attached.

Sources: KD Tripathi 7e·Verified: 2026-05-10 · House clinical team